Clinical Trial Update: Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating lapatinib in combination with radiation therapy for brain metastases from HER2-positive breast cancer. Results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: Nancy Lin, MD | Conditions: Breast Cancer, Brain Metastases | Phase 1 | Status: COMPLETED | Results posted: 2014-01-20